Clinical Trials Directory

Trials / Completed

CompletedNCT05964088

Mortality and Morbidity Associated With New Onset Acute Kidney Injury in Critically Ill COVID-19 Infection Patients

Status
Completed
Phase
Study type
Observational
Enrollment
267 (actual)
Sponsor
Arrowhead Regional Medical Center · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This study explored the incidence of morbidity and mortality associated with AKI in critically ill adult patients infected with COVID-19. There are two groups for comparison. Group1. patients were directly admitted to the intensive care unit (ICU) from the emergency department (ED) Group 2. patients were initially managed on the medical floor and later transferred to the ICU for worsening respiratory status. The investigating team evaluated the correlation of inflammatory markers and common risk factors such as obesity, diabetes, hypertension and ethnicity to the development of AKI in the target population. The primary outcome is mortality participants will received their regular healthcare in a medical setting

Conditions

Timeline

Start date
2020-03-01
Primary completion
2022-02-12
Completion
2022-02-12
First posted
2023-07-27
Last updated
2023-07-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05964088. Inclusion in this directory is not an endorsement.